All articles by Nikki Thompson

Nikki Thompson

A preferred destination: what’s driving Asia Pacific’s growth as a clinical trial hotspot

Research from GlobalData shows that the Asia-Pacific (APAC) region was the largest contributor to the global clinical trial landscape from…

Untapped opportunity: the growing potential of clinical trials in Georgia

In the wake of Russia’s invasion of Ukraine, sponsors are increasingly evaluating other European countries to conduct their clinical trials.…

Abacus Medicine Pharma Services on their Success with Warm Lead Generation

Abacus Medicine Pharma Services wanted lead generation for their Clinical Trial Solutions (CTS) services. They needed thought leadership content that…

Accelerating transit times and lowering the cost of comparator sourcing for studies in Africa

To understand why sub-Saharan Africa can appear a daunting prospect to a contract research organisation (CRO) or sponsor looking to…

From hashtags to humility: nine simple steps to better pharma social content

Creating pharmaceutical social campaigns that resonate and engage the relevant audience is no mean feat. Not only is the pharma…

Africa’s last mile: Building viable vaccine supply chains

Lack of access to vaccines leads to 1.5 million preventable deaths each year[1]. In Africa alone, approximately one in five…

Making the Most of Site Training: Lessons from the Pandemic

The investigator meeting and site initiation visit (SIV) are two critical milestones marking the beginning of a clinical trial for members of the site team.

Waste mitigation in clinical trials: How to optimise your drug inventories

Clinical trials require the holistic management of a lot of moving parts and increasingly so, as more and more clinical…

Digitalization trends shaping outpatient clinical trials in 2021

Covid-19 has had a devastating impact on outpatient clinical trials through temporary suspensions, reduced recruitment and trial delays. It has also helped to facilitate digital transformation at an unprecedented rate.

The benefit of running clinical trials in Asia-Pacific for biotech companies

According to Frost & Sullivan, the CRO market is forecast to grow to US$ 71.7billion by 2024 (+8% CAGR 19-24F).…